Emily Conley - 23 Aug 2024 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Aug 2024, 16:44:45 UTC
Prior SEC filing
16 Jul 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nathan McConarty, attorney-in-fact

Key filing fact

Emily Conley filed Form 4 for Nuvalent, Inc. (NUVL) on 27 Aug 2024.

Key facts

  • This page summarizes Emily Conley's Form 4 filing for Nuvalent, Inc. (NUVL).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 Aug 2024, 16:44.

Change

  • Previous filing in this sequence was filed on 16 Jul 2024.
  • Current net transaction value: -$237,481.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUVL transaction

Class A Common Stock

Options Exercise

Transaction value
$45,976
Shares
+3,334
Change %
+133%
Price
$13.79
Shares after
5,841
Date
23 Aug 2024
Ownership
Direct
Footnotes
F1
NUVL transaction

Class A Common Stock

Sale

Transaction value
$283,457
Shares
-3,334
Change %
-57%
Price
$85.02
Shares after
2,507
Date
23 Aug 2024
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUVL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-3,334
Change %
-13%
Price
$0.000000
Shares after
23,333
Date
23 Aug 2024
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
3,334
Exercise price
$13.79
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2023.

Footnote F2

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.09, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.

Footnote F3

The shares underlying this option have vested or shall vest over the three years following February 2, 2022 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .